These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29414252

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH, Packer M, Gill GS, Wu WC, Levy WC, Zile MR, Brar V, Arundel C, Cheng Y, Singh SN, Allman RM, Fonarow GC, Ahmed A.
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [Abstract] [Full Text] [Related]

  • 4. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
    Tannenbaum S, Sayer GT.
    Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
    [Abstract] [Full Text] [Related]

  • 5. Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.
    Lekavich CL, Barksdale DJ, Neelon V, Wu JR.
    Heart Fail Rev; 2015 Nov; 20(6):643-53. PubMed ID: 26404098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L, Adhyaru B.
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [Abstract] [Full Text] [Related]

  • 9. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
    Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F.
    Hypertension; 2020 Jan; 75(1):23-32. PubMed ID: 31786973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.
    Pugliese NR, Masi S, Taddei S.
    Heart Fail Rev; 2020 Jan; 25(1):31-42. PubMed ID: 31512149
    [Abstract] [Full Text] [Related]

  • 12. Current challenges in the management of heart failure.
    Komajda M.
    Circ J; 2015 Jan; 79(5):948-53. PubMed ID: 25877621
    [Abstract] [Full Text] [Related]

  • 13. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
    From AM, Borlaug BA.
    Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV, PARADIGM-HF and ATMOSPHERE Investigators and Committees.
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MY APPROACH to heart failure with preserved ejection fraction.
    Borlaug BA.
    Trends Cardiovasc Med; 2014 Nov; 24(8):369-70. PubMed ID: 25267507
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.